ArticleEmerging infectious diseases2015
Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States.
Article in Emerging infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 40 citations in OpenAlex.
- Leveraging large language models on free-text symptoms from participatory surveillance enhances pertussis forecasting in the United States.BMC infectious diseases · 2026Article
- Article
- Variation in virulence between three representativemSphere · 2025Article
- Fever Among Pertussis Cases Reported Through Enhanced Pertussis Surveillance, 2015-2022.Open forum infectious diseases · 2025Article
- StrengtheningJournal of clinical microbiology · 2024Article
- Differences in Pertussis Incidence by Race and Ethnicity in the United States, 2010-2017.Open forum infectious diseases · 2024Article
- Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination.Scientific reports · 2022Article
- Pertussis prevalence among adult patients with acute cough.Turkish journal of medical sciences · 2022Article
- Multivariate Tail Probabilities: Predicting Regional Pertussis Cases in Washington State.Entropy (Basel, Switzerland) · 2021Article
- Genomic Surveillance and Improved Molecular Typing of Bordetella pertussis Using wgMLST.Journal of clinical microbiology · 2021Article
- Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021Observational
- iGIST-A Kinetic Bioassay for Pertussis Toxin Based on Its Effect on Inhibitory GPCR Signaling.ACS sensors · 2020Article
- Article
- Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants - United States.MMWR. Morbidity and mortality weekly report · 2019Article
- Severe Pertussis Infections in the United States, 2011-2015.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019Article
- Genomic Survey of Bordetella pertussis Diversity, United States, 2000-2013.Emerging infectious diseases · 2019Article
- Prevention of pertussis: from clinical trials to Real World Evidence.Journal of preventive medicine and hygiene · 2018Article
- Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.Infection and immunity · 2018Article
- Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017Article
- Complete Genome Sequences ofGenome announcements · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite high coverage with pertussis-containing vaccines, pertussis remains endemic to the United States. There have been increases in reported cases in recent years, punctuated by striking epidemics and shifting epidemiology, both of which raise questions about current policies regarding its prevention and control. Limited data on pertussis reported through the National Notifiable Disease Surveillance System have proved insufficient to answer these questions. To address shortcomings of national pertussis data, the Emerging Infections Program at the US Centers for Disease Control and Prevention launched Enhanced Pertussis Surveillance (EPS), which is characterized by systematic case ascertainment, augmented data collection, and collection of Bordetella pertussis isolates. Data collected through EPS have been instrumental in understanding the rapidly evolving epidemiology and molecular epidemiology of pertussis and have contributed essential information regarding pertussis vaccines. EPS also serves as a platform for conducting critical and timely evaluations of pertussis prevention and control strategies, including targeting of vaccinations and antimicrobial prophylaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.